Administration of a vasoactive intestinal peptide antagonist enhances the autologous anti-leukemia T cell response in murine models of acute leukemia.
about
Administration of a vasoactive intestinal peptide antagonist enhances the autologous anti-leukemia T cell response in murine models of acute leukemia.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Administration of a vasoactive ...... rine models of acute leukemia.
@en
type
label
Administration of a vasoactive ...... rine models of acute leukemia.
@en
prefLabel
Administration of a vasoactive ...... rine models of acute leukemia.
@en
P2093
P2860
P1433
P1476
Administration of a vasoactive ...... rine models of acute leukemia.
@en
P2093
Christopher T Petersen
Edmund K Waller
Jian-Ming Li
P2860
P304
P356
10.1080/2162402X.2017.1304336
P577
2017-03-16T00:00:00Z